Literature DB >> 173072

Tissue-steroid interactions in canine hormone-dependent tumours.

C R Evans, C G Pierrepoint.   

Abstract

Mammary tumour tissue from two bitches and an anal adenoma from a dog were investigated for steroid receptor interaction. Both mammary tumours possessed cytoplasmic macromolecules sedimenting with coefficients of 4S and 8S that bound oestradiol-17beta. These receptors had molecular weights of approximately 60,000 and 180,000 respectively. Transfer of the oestrogen to the nucleus was shown and the presence of a 4-5S nuclear protein demonstrated. The anal adenoma had a cytoplasmic receptor, with a sedimentation value in a sucrose density gradient of 4-5S with respect to bovine serum albumin, that bound tritiated 5alpha-androstane-3alpha, 17alpha-diol. No affinity could be demonstrated for other C19-steroids examined. The significance of these findings in terms of the hormone dependence of the tumours investigated and the possible development of these studies to promote rational therapy in such cases is discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 173072

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  4 in total

1.  Cyclosporine treatment of perianal gland adenoma concurrent with benign prostatic hyperplasia in a dog.

Authors:  Chul Park; Jong-Hyun Yoo; Ha-Jung Kim; Chae-Young Lim; Ju-Won Kim; So-Young Lee; Jung-Hyun Kim; Jae-Im Jang; Hee-Myung Park
Journal:  Can Vet J       Date:  2010-11       Impact factor: 1.008

2.  Presidential address. Comparative oncology: the veterinary contribution.

Authors:  E Cotchin
Journal:  Proc R Soc Med       Date:  1976-09

3.  Simultaneous occurrence of receptors for estradiol, progesterone, and dihydrotestosterone in canine mammary tumors.

Authors:  H Elling; F R Ungemach
Journal:  J Cancer Res Clin Oncol       Date:  1983       Impact factor: 4.553

4.  Research at the Tenovus Institute.

Authors:  K Griffiths
Journal:  J R Coll Physicians Lond       Date:  1976-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.